Sugimoto Kazuhisa, Nishimura Takahisa, Nomura Koji, Sugimoto Kenji, Kuriki Takashi
Biochemical Research Laboratory, Ezaki Glico Co., Ltd, Osaka, Japan.
Chem Pharm Bull (Tokyo). 2003 Jul;51(7):798-801. doi: 10.1248/cpb.51.798.
The effects of 4-hydroxyphenyl alpha-glucopyranoside (alpha-arbutin) and 4-hydroxyphenyl beta-glucopyranoside (arbutin) on the activity of tyrosinase from human malignant melanoma cells were examined. The inhibitory effect of alpha-arbutin on human tyrosinase was stronger than that of arbutin. The K(i) value for alpha-arbutin was calculated to be 1/20 that for arbutin. We then synthesized arbutin-alpha-glycosides by the transglycosylation reaction of cyclomaltodextrin glucanotransferase using arbutin and starch, respectively, as acceptor and donor molecules. The structural analyses using 13C- and 1H-NMR proved that the transglycosylated products were 4-hydroxyphenyl beta-maltoside (beta-Ab-alpha-G1) and 4-hydroxyphenyl beta-maltotrioside (beta-Ab-alpha-G2). These arbutin-alpha-glycosides exhibited competitive type inhibition on human tyrosinase, and their K(i) values were calculated to be 0.7 mM and 0.9 mM, respectively. These arbutin-alpha-glycosides possessed stronger inhibitory activity than arbutin, but less activity than alpha-arbutin. These results suggested that the alpha-glucosidic linkage of hydroquinone-glycosides plays an important role in the inhibitory effect on human tyrosinase.
研究了4-羟基苯基α-D-吡喃葡萄糖苷(α-熊果苷)和4-羟基苯基β-D-吡喃葡萄糖苷(熊果苷)对人恶性黑色素瘤细胞酪氨酸酶活性的影响。α-熊果苷对人酪氨酸酶的抑制作用强于熊果苷。计算得出α-熊果苷的K(i)值为熊果苷的1/20。然后,分别以熊果苷和淀粉作为受体和供体分子,通过环糊精葡聚糖转移酶的转糖基化反应合成了熊果苷-α-糖苷。使用13C-和1H-NMR进行的结构分析证明,转糖基化产物为4-羟基苯基β-麦芽糖苷(β-Ab-α-G1)和4-羟基苯基β-麦芽三糖苷(β-Ab-α-G2)。这些熊果苷-α-糖苷对人酪氨酸酶表现出竞争性抑制类型,其K(i)值分别计算为0.7 mM和0.9 mM。这些熊果苷-α-糖苷具有比熊果苷更强的抑制活性,但比α-熊果苷活性低。这些结果表明,对苯二酚-糖苷的α-糖苷键在对人酪氨酸酶的抑制作用中起重要作用。